Archive
Inflation numbers from UK and US to be eyed closely in coming week amid rate hike fears
Week ahead includes the latest UK and US consumer price indexes, plus corporate updates from RELX PLC, Coca Cola HBC PLC, Shire PLC and ConvaTec PLC
Company
AstraZeneca PLC
LON:AZN
AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.
1084 stories · page 39 of 55
AstraZeneca: Trump tax bump can't disguise the challenge it and other druggies face
AZ is one of a number of UK companies with significant US operations to update on the benefits of cutting the corporate tax rate to 21% from 35%
FTSE 100 slides as dollar rallies on expectations of a March rate hike by the Fed
US workers' pay increased 2.9% year-on-year, compared to expectations of a 2.6% increase.
Archive
Day ahead: BT and AstraZeneca quarterly earnings, US non-farm payrolls
The day ahead includes quarterly earnings from BT and AstraZeneca as well as the US non-farm payrolls report
FTSE 100 ends lower as pound firms; housebuilders weigh
Britain's top tier index closed around 54 points lower at 7,533
FTSE 100 closes higher, just, with miners in support
The FTSE 100, dragged higher by the miners, got off to a strong start today, but closed juts about six points higher
Archive
Unilever among the quality blue chip updates scheduled, but Fed meeting and US jobs data more important
Week ahead includes updates from FTSE 100 AstraZeneca PLC, BT Group PLC, Royal Dutch Shell PLC, and Unilever PLC, plus a Federal Reserve meeting and January US jobs data
AstraZeneca reports positive top-line data from phase III COPD trial
The KRONOS trial showed that Astra’s PT010 inhaler can improve lung function in patients with moderate to severe chronic obstructive pulmonary disease
New York's BIO CEO & Investor conference brings biotech investors, companies and analysts together
Now in its 20th year, the conference brings investors, analysts, and management of companies together
Investments and investor services
FTSE 100 closes in the red as sterling booms
“If he intended it, Treasury Secretary Steven Mnuchin has done a first class job of whacking the dollar,” declared Neil Wilson at ETX Capital. .
AstraZeneca gets approval for two cancer and asthma treatments in Japan
Lynparza has been approved for use as a maintenance therapy in ovarian cancer patients, while Fasenra has been cleared as an add-on treatment for severe asthma sufferers
Circassia and AstraZeneca to widen scope of COPD inhaler after post-launch trial success
AstraZeneca intends to file for the trial data to be included to widen the marketing label for Turdoza
AstraZeneca submits supplemental new drug application for Tagrisso in Japan
The new drug application follows positive phase II trial results
AstraZeneca shares up 1.2% after getting regulatory green light for asthma drug
The US Food & Drug Administration gave the thumbs up overnight
AstraZeneca lifts full-year core earnings guidance
Full-year earnings will still be in a bit of a Soriot-state, but won't decline as much as previously expected
FTSE 100 firmly in red as EU cuts growth forecasts for UK
After a bullish run over the past few months, European and US markets endured a rare off day on Thursday
Archive
AstraZeneca's results: focus will be on the pipeline and recovery options for the MYSTIC trial
Will Astra get into the MYSTIC? The company said not all hope was lost for its lung cancer trial, which flunked in the summer
Archive
M&S and Sainsbury's take centre stage as BoE interest rate hike excitement dies down
The week ahead includes earnings from M&S, Sainsbury's, ABF, Direct Line, Wetherspoon and AstraZeneca while macro-economic announcements will be thin on the ground
AstraZeneca’s severe asthma treatment fails in late-stage study but FDA approval of rare blood cancer drug boosts shares
Investors were more interested in Tuesday evening’s news that the US FDA had approved Calquence as a treatment for people with mantle cell lymphoma
AstraZeneca edges higher after double dose of updates on cancer and diabetes drugs
A new formulation of Astra’s diabetes drug has been given the green light by the FDA, while it has submitted a second NDA in Japan for its Lynparza cancer drug, this time for use in breast cancer